(NASDAQ: NOTV) Inotiv's forecast annual revenue growth rate of -1.09% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 2.48%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.86%.
Inotiv's revenue in 2024 is $585,172,000.On average, 1 Wall Street analysts forecast NOTV's revenue for 2024 to be $14,927,129,770, with the lowest NOTV revenue forecast at $14,927,129,770, and the highest NOTV revenue forecast at $14,927,129,770.
In 2025, NOTV is forecast to generate $15,554,874,922 in revenue, with the lowest revenue forecast at $15,554,874,922 and the highest revenue forecast at $15,554,874,922.